Moximak tablets 400 mg No. 5




Moximac tablets are indicated for:
Community-acquired pneumonia. Complicated skin and subcutaneous tissue infections. Moxifloxacin should only be used when other antibacterial agents that are usually recommended for the initial treatment of these infections are inappropriate. Official guidance on the appropriate use of antibacterial agents should be consulted.Composition
active ingredient: moxifloxacin;
1 container (250 ml of solution) contains moxifloxacin hydrochloride equivalent to moxifloxacin 400 mg;
Excipients: sodium chloride, diluted hydrochloric acid, sodium hydroxide, water for injections.
Contraindication
Hypersensitivity to moxifloxacin, other quinolone antibiotics or to any of the excipients; pregnancy or breastfeeding (see section "Use during pregnancy or breastfeeding"); childhood (up to 18 years); history of tendon disease/pathology associated with the use of quinolones.Method of application
The drug should be administered intravenously as a continuous infusion lasting at least 60 minutes (see also the section "Special instructions for use").
If indicated, the infusion solution can be administered via a T-catheter together with compatible infusion solutions (see section "Special precautions").
Application features
Pregnant women
Contraindicated.
Children
Contraindicated.
Drivers
Patients are advised to check their reaction to moxifloxacin before driving or operating other machinery.
Overdose
No specific measures are recommended after accidental overdose. In case of overdose, symptomatic treatment should be carried out. Since QT interval prolongation is possible, ECG monitoring is required. Co-administration of activated charcoal with a dose of moxifloxacin 400 mg administered orally or intravenously reduces the systemic bioavailability of the drug by more than 80% or 20%, respectively. Administration of activated charcoal at the initial stage of absorption may be effective in preventing excessive increase in systemic exposure to moxifloxacin in case of overdose after oral administration of the drug.
Side effects
Common: increased gamma-glutamyltransferase.
Uncommon: ventricular tachyarrhythmia, hypotension, oedema, antibiotic-associated colitis (including pseudomembranous colitis, in rare cases associated with life-threatening complications, see section 4.4), seizures (including grand mal seizures) (see section 4.4), hallucinations, renal impairment (including increases in blood urea nitrogen and creatinine), renal failure (see section 4.4).
Interaction
Moxifloxacin does not show clinically significant interactions with food, including dairy products.
Storage conditions
Store at a temperature not exceeding 25 °C in the original packaging. Do not refrigerate.
Keep out of reach of children.
Shelf life - 2 years.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.